Whitehawk Therapeutics (WHWK) Treasury Shares (2015 - 2026)
Whitehawk Therapeutics (WHWK) reported Treasury Shares of $2.4 million for Q1 2026, up 1376.99% year-over-year from $161721.0 in Q1 2025, and down 2.61% on a QoQ basis from $2.5 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 8 years of Treasury Shares data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Treasury Shares rose 1376.99% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1376.99% YoY) and the FY2025 annual result came in at $2.5 million, up 856.25% from the prior year.
- Treasury Shares slipped to $2.4 million in Q1 2026 per WHWK's latest filing, from $2.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.5 million in Q4 2025 and bottomed at $32558.0 in Q4 2023.
- The 4-year median for Treasury Shares is $337553.0 (2024), against an average of $1.1 million.
- The widest annual swing landed in 2025, when Treasury Shares tumbled 52.61%; it then surged 1376.99% in 2026.
- Tracing WHWK's Treasury Shares over 4 years: stood at $32558.0 in 2023, then surged by 687.79% to $256490.0 in 2024, then jumped by 856.25% to $2.5 million in 2025, then slipped by 2.61% to $2.4 million in 2026.
- Per Business Quant, the three latest WHWK Treasury Shares figures stand at $2.4 million (Q1 2026), $2.5 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 161,721.00 |
| Mar 31, 2025 | 161,721.00 |
| Dec 31, 2024 | 256,490.00 |
| Dec 31, 2024 | 256,490.00 |
| Sep 30, 2024 | 317,408.00 |
| Sep 30, 2024 | 317,408.00 |
| Jun 30, 2024 | 333,848.00 |
| Jun 30, 2024 | 333,848.00 |
| Mar 31, 2024 | 341,258.00 |
| Mar 31, 2024 | 341,258.00 |
| Dec 31, 2023 | 32,558.00 |
| Dec 31, 2023 | 32,558.00 |
| Sep 30, 2018 | 7,038.00 |
| Sep 30, 2018 | 7,038.00 |
| Jun 30, 2018 | 52,223.00 |
| Jun 30, 2018 | 52,223.00 |
| Mar 31, 2018 | 80,230.00 |
| Mar 31, 2018 | 80,230.00 |
| Dec 31, 2017 | 91,576.00 |
| Dec 31, 2017 | 91,576.00 |
| Sep 30, 2017 | 129,835.00 |
| Sep 30, 2017 | 129,835.00 |
| Jun 30, 2017 | 168,724.00 |
| Jun 30, 2017 | 168,724.00 |
| Mar 31, 2017 | 196,419.00 |
| Mar 31, 2017 | 196,419.00 |
| Dec 31, 2016 | 241,096.00 |
| Dec 31, 2016 | 241,096.00 |
| Dec 31, 2015 | 444,199.00 |
| Dec 31, 2015 | 444,199.00 |